CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high
$10.88
Daily low
$9.65
Price at open
$9.97
52 Week High
$14.60
52 Week Low
$1.34
Market cap
423.4M
Dividend yield
0.00%
Volume
1.7M
Avg. volume
866,270
P/E ratio
-5.47

Candel Therapeutics News

Details

Daily high
$10.88
Daily low
$9.65
Price at open
$9.97
52 Week High
$14.60
52 Week Low
$1.34
Market cap
423.4M
Dividend yield
0.00%
Volume
1.7M
Avg. volume
866,270
P/E ratio
-5.47